Role of the influenza virus nonstructural 1 protein in evasion of immunity

Future Virology

Volumn 2, Issue 4, 2007, Pages 389-399

  Fernandez Sesma, Ana ^a   Moran, Thomas M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

2 5 oligoadenylate synthetase; Antigen presenting cells; Dendritic cells; IFN receptor 1; IFN inducible protein of 10 kDa; IFN inducible protein of 56 kDa; IFN regulatory factor; Myxovirus resistance protein A; Nonstructural protein 1; Nuclear factor B; Quantitative real time PCR; Retinoic acid inducible gene I; T helper; Toll like receptor; Tumor necrosis factor

Indexed keywords

ANTIVIRUS AGENT; CYTOPLASM PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLUENZA VACCINE; INTERFERON; INTERFERON REGULATORY FACTOR 3; LIVE VACCINE; NONSTRUCTURAL PROTEIN 1; RETINOIC ACID INDUCIBLE PROTEIN 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; ANTIVIRAL ACTIVITY; CELL MATURATION; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE INTERACTION; GENE TARGETING; IMMUNE RESPONSE; IMMUNOMODULATION; INFLUENZA VIRUS; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; RNA PROCESSING; RNA TRANSLATION; T LYMPHOCYTE; VIRUS IMMUNITY; VIRUS RECOMBINANT;

ORTHOMYXOVIRIDAE;

EID: 34447301223     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460794.2.4.389     Document Type: Review

References (76)

1. Honda K, Yanai H, Takaoka A, Taniguchi T: Regulation of the type I IFN induction: a current view. Int. Immunol. 17, 1367-1378 (2005).
2. Basler CF, Garcia-Sastre A: Sensing RNA virus infections. Nat. Chem. Biol. 3, 20-21 (2007).
3. Levy DE, García-Sastre A: The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev. 12, 143-156. (2001).
4. Garcia-Sastre A: Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 279, 3753-3784 (2001).
5. Garcia-Sastre A: Mechanisms of inhibition of the host interferon alpha/ beta-mediated antiviral responses by viruses. Microbes Infect. 4, 647-655 (2002).
6. Alcami A, Koszinowski UH: Viral mechanisms of immune evasion. Trends Microbiol. 8, 410-418 (2000).
7. Palese P, Garcia-Sastre A: Influenza vaccines: present and future. J. Clin. Invest. 110, 9-13 (2002).
8. Fernandez-Sesma A, Marukian S, Ebersole BJ et al.: Influenza virus evades innate and adaptive immunity via the NS1 protein. J. Virol. 80, 6295-6304 (2006).
9. García-Sastre A, Egorov A, Matassov D et al.: Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252, 324-330 (1998).
10. López CB, García-Sastre A, Williams BRG, Moran TM: Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses. J. Infect. Dis. 187, 1126-1136 (2003).
11. Talon J, Salvatore M, O'Neill RE et al.: Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proc. Natl. Acad. Sci. USA 97, 4309-4314 (2000).
12. Wang X, Li M, Zheng H et al.: Influenza A virus NS1 protein prevents the activation of NF-κB and induction of type I IFN. J. Virol. 74, 11566-11573 (2000).
13. Bergmann M, Garcia-Sastre A, Carnero E et al.: Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J. Virol. 74, 6203-6206 (2000).
14. Dauber B, Schneider J, Wolff T: Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of α/βinterferon. J. Virol. 80, 11667-11677 (2006).
15. Li S, Min JY, Krug RM, Sen GC: Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349, 13-21 (2006).
16. Min JY, Krug RM: The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc. Natl. Acad. Sci. USA 103, 7100-7105 (2006).
17. Talon J, Horvath CM, Polley R et al.: Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J. Virol. 74, 7989-7996 (2000).
18. Ludwig S, Wang X, Ehrhardt C et al.: The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J. Virol. 76, 11166-11171 (2002).
19. Wang W, Riedel K, Lynch P, Chien CY, Montelione GT, Krug RM: RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 5, 195-205 (1999).
20. Guo Z, Chen LM, Zeng H et al.: NS1 protein of Influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am. J. Respir. Cell Mol. Biol. 36(3), 263-269 (2006).
21. Mibayashi M, Martínez-Sobrido L, Loo YM, Cárdenas WB, Gale M, García-Sastre A: Inhibition of retinoic acid-inducible gene I-mediated induction of β interferon by the NS1 protein of influenza A virus. J. Virol. 81, 514-524 (2007).
22. Pichlmair A, Schulz O, Tan CP et al.: RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314, 997-1001 (2006).
23. Hornung V, Ellegast J, Kim S et al.: 5′-triphosphate RNA is the ligand for RIG-I. Science 314, 994-997 (2006).
24. Donelan NR, Basler CF, Garcia-Sastre A: A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J. Virol. 77, 13257-13266 (2003).
25. Salvatore M, Basler CF, Parisien JP et al.: Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J. Virol. 76, 1206-1212 (2002).
26. de la Luna S, Fortes P, Beloso A, Ortín J: Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J. Virol. 69, 2427-2433 (1995).
27. Fortes P, Beloso A, Ortín J: Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J. 13, 704-712 (1994).
28. Lu Y, Qian XY, Krug RM: The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev. 8, 1817-1828 (1994).
29. Lu Y, Wambach M, Katze MG, Krug RM: Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214, 222-228 (1995).
30. Marión RM, Aragón T, Beloso A, Nieto A, Ortín J: The N-terminal half of the influenza virus NS1 protein is sufficient for nuclear retention of mRNA and enhancement of viral mRNA translation. Nucleic Acids Res. 25, 4271-4277 (1997).
31. Marión RM, Zürcher T, de la Luna S, Ortín J: Influenza virus NS1 protein interacts with viral transcription-replication complexes in vivo. J. Gen. Virol. 78, 2447-2451 (1997).
32. Zürcher T, Marión RM, Ortín J: Protein synthesis shut-off induced by influenza virus infection is independent of PKR activity. J. Virol. 74, 8781-8784 (2000).
33. Qiu Y, Krug RM: The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J. Virol. 68, 2425-2432 (1994).
34. Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM: Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′end formation of cellular pre-mRNAs. Mol. Cell 1, 991-1000 (1998).
35. Satterly N, Tsai PL, van Deursen J et al.: Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc. Natl. Acad. Sci. USA 104, 1853-1858 (2007).
36. Ehrhardt C, Marjuki H, Wolff T et al.: Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell Microbiol. 8, 1336-1348 (2006).
37. Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE: Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc. Natl Acad. Sci. USA 103, 14194-14199 (2006).
38. Ehrhardt C, Wolff T, Pleschka S et al.: Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J. Virol. 81, 3058-3067 (2007).
39. Hale BG, Randall RE: PI3K signalling during influenza A virus infections. Biochem. Soc. Trans. 35, 186-187 (2007).
40. Shin YK, Liu Q, Tikoo SK, Babiuk LA, Zhou Y: Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation. J. Gen. Virol. 88, 942-950 (2007).
41. Shin YK, Liu Q, Tikoo SK, Babiuk LA, Zhou Y: Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3 K. J. Gen. Virol. 88, 13-18 (2007).
42. Zhirnov OP, Klenk HD: Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling. Apoptosis (2007) (Epub ahead of print).
43. Barton GM, Medzhitov R: Toll-like receptors and their ligands. Curr. Top. Microbiol. Immunol. 270, 81-92 (2002).
44. Blander JM, Medzhitov R: Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440, 808-812 (2006).
45. Iwasaki A, Medzhitov R: Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987-995 (2004).
46. Yoneyama M, Kikuchi M, Natsukawa T et al.: The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730-737 (2004).
47. Kato H, Takeuchi O, Sato S et al.: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101-105 (2006).
48. Barchet W, Cella M, Colonna M: Plasmacytoid dendritic cells-virus experts of innate immunity. Semin. Immunol. 17, 253-261 (2005).
49. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
50. Banchereau J, Briere F, Caux C et al.: Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811 (2000).
51. Cella M, Sallusto F, Lanzavecchia A: Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9, 10-16 (1997).
52. Mellman I, Steinman RM: Dendritic cells: specialized and regulated antigen processing machines. Cell 106, 255-258 (2001).
53. Steinman RM, Inaba K, Turley S, Pierre P, Mellman I: Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum. Immunol. 60, 562-567 (1999).
54. Haeryfar SM: The importance of being a pDC in antiviral immunity: the IFN mission versus Ag presentation? Trends Immunol. 26, 311-317 (2005).
55. Bonifaz LC, Bonnyay DP, Charalambous A et al.: In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199, 815-824 (2004).
56. Brimnes MY, Bonifaz L, Steinman RM, Moran TM: Influenza virus-induced dendritic cell maturation is associated with the induction of strong T cell immunity to a coadministered, normally nonimmunogenic protein. J. Exp. Med. 198, 133-144 (2003).
57. Geiss GK, Salvatore M, Tumpey TM et al.: Cellular transcriptional profiling in influenza A virus infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc. Natl Acad. Sci. USA 99, 10736-10741 (2002).
58. Chen Z, Li Y, Krug RM: Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery. EMBO J. 18, 2273-2283 (1999).
59. Balachandran S, Thomas E, Barber GN: A FADD-dependent innate immune mechanism in mammalian cells. Nature 432, 401-405 (2004).
60. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C: Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529-1531 (2004).
61. Heil F, Hemmi H, Hochrein H et al.: Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303, 1526-1529 (2004).
62. Iwasaki A: Division of labor by dendritic cells. Cell 128, 435-436 (2007).
63. Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A: Autophagy-dependent viral recognition by plasmacytoid dendritic cell. Science (2007) (Epub ahead of print).
64. Fujii S, Liu K, Smith C, Bonito AJ, Steinman RM: The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199, 1607-1618 (2004).
65. López CB, Moltedo B, Alexopoulou L, Bonifaz L, Flavell RA, Moran TM: Toll-like receptor-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses. J. Immunol. 173, 6882-6889 (2004).
66. Honda K, Sakaguchi S, Nakajima C et al.: Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc. Natl Acad. Sci. USA 100, 10872-10877 (2003).
67. Savina A, Jancic C, Hugues S et al.: NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126, 205-218 (2006).
68. Ackerman AL, Giodini A, Cresswell P: A role for the endoplasmic reticulum protein retrotranslocation machinery during cross-presentation by dendritic cells. Immunity 25, 607-617 (2006).
69. Villadangos JA, Heath WR, Carbone FR: Outside looking in: the inner workings of the cross-presentation pathway within dendritic cells. Trends Immunol. 28, 45-47 (2007).
70. Dauber B, Heins G, Wolff T: The influenza B virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction. J. Virol. 78, 1865-1872 (2004).
71. Durbin JE, Fernandez-Sesma A, Lee CK et al.: Type I IFN modulates innate and specific antiviral immunity. J. Immunol. 164, 4220-4228 (2000).
72. Falcón AM, Fernandez-Sesma A, Nakaya Y, Moran TM, Ortín J, García-Sastre A: Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins. J. Gen. Virol. 86, 2817-2821 (2005).
73. Quinlivan M, Zamarin D, García-Sastre A, Cullinane A, Chambers T, Palese P: Attenuation of equine influenza viruses through truncations of the NS1 protein. J. Virol. 79, 8431-8439 (2005).
74. Richt JA, Lekcharoensuk P, Lager KM et al.: Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine. J. Virol. 80, 11009-11018 (2006).
75. Solórzano A, Webby RJ, Lager KM, Janke BH, García-Sastre A, Richt JA: Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J. Virol. 79, 7535-7543 (2005).
76. Ferko B, Stasakova J, Romanova J et al.: Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J. Virol. 78, 13037-13045 (2004).